25,214 Shares in Heartflow, Inc. $HTFL Bought by HB Wealth Management LLC

HB Wealth Management LLC bought a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 25,214 shares of the company’s stock, valued at approximately $613,000.

Several other large investors also recently modified their holdings of the business. TrueMark Investments LLC raised its position in shares of Heartflow by 1.4% during the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after purchasing an additional 379 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow in the 4th quarter valued at approximately $27,000. Strs Ohio increased its stake in Heartflow by 35.3% during the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after purchasing an additional 1,200 shares in the last quarter. Russell Investments Group Ltd. acquired a new stake in Heartflow during the 4th quarter worth approximately $45,000. Finally, Legal & General Group Plc bought a new position in Heartflow in the third quarter valued at approximately $59,000.

Insider Activity at Heartflow

In related news, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the business’s stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $29.23, for a total transaction of $27,732,167.11. Following the transaction, the insider directly owned 8,448,158 shares in the company, valued at approximately $246,939,658.34. The trade was a 10.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO John C.M. Farquhar sold 38,900 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares in the company, valued at $16,027,725. This trade represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 2,093,243 shares of company stock valued at $61,819,648. 7.70% of the stock is owned by corporate insiders.

Heartflow Stock Performance

HTFL opened at $26.72 on Friday. The business’s 50-day simple moving average is $30.19 and its 200 day simple moving average is $28.67. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $41.22. The firm has a market capitalization of $2.30 billion and a PE ratio of -8.59.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million during the quarter. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. On average, research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Wells Fargo & Company upped their price target on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Canaccord Genuity Group cut their price objective on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. Weiss Ratings lowered shares of Heartflow from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Finally, JPMorgan Chase & Co. cut their price target on Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, March 19th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $37.00.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.